Jialu Xu | Neuroscience | Best Researcher Award

Dr. Jialu Xu | Neuroscience | Best Researcher Award

Huazhong University of Science and Technology | China

Author Profile 

Orcid

Early Academic Pursuits 🎓

Dr. Jialu Xu has shown remarkable dedication to scientific research from early on in his academic journey. Having pursued a strong foundation in biomedical sciences, his commitment to understanding complex biological mechanisms has been evident through his involvement in various academic projects. His educational background at Huazhong University of Science and Technology laid the groundwork for his focus on biomedical research, particularly in the study of cognitive impairment and its underlying causes.

Professional Endeavors 💼

Dr. Xu is currently affiliated with Huazhong University of Science and Technology, where he actively contributes to research at Tongji Hospital. His work is interdisciplinary, spanning both clinical and laboratory settings. Dr. Xu's professional role has been instrumental in investigating the intricate pathways involved in cognitive diseases, where he collaborates with colleagues on cutting-edge research projects aimed at improving patient care and advancing scientific knowledge.

Contributions and Research Focus 🔬

One of Dr. Xu's most significant contributions is his study on how high-carbohydrate diets can lead to cognitive impairment. His research, published in Biomedicines in July 2024, demonstrates how these diets promote amyloid burden and tau phosphorylation through the PI3K/Akt/GSK-3β pathway in db/db mice. This groundbreaking work provides insights into the molecular mechanisms underlying neurodegenerative diseases like Alzheimer’s, opening doors to potential new therapeutic interventions. His research interests encompass neurology, metabolic disorders, and molecular pathways related to brain health.

Accolades and Recognition 🏆

Dr. Xu’s innovative research has garnered recognition in the scientific community. His recent publication in Biomedicines has been well-received, highlighting his growing reputation as a leader in cognitive impairment research. His work has contributed to expanding the knowledge base around neurodegenerative disorders and is recognized for its potential impact on future treatments.

Impact and Influence 🌍

Dr. Xu’s research not only influences the academic community but also has far-reaching implications for public health, especially in areas related to diet and neurodegenerative diseases. His findings on the impact of high-carbohydrate diets on cognitive health offer valuable guidance for clinicians and dieticians in developing preventive strategies and interventions for at-risk populations.

Legacy and Future Contributions 🌟

As Dr. Xu continues to expand his research, his future contributions are poised to significantly advance the understanding of cognitive diseases. His ongoing work will likely explore more innovative solutions to mitigate the effects of poor dietary habits on brain health. Dr. Xu’s legacy will be one of pioneering research that bridges the gap between molecular biology and practical health outcomes, ensuring his work leaves a lasting mark on the fields of neurology and dietary science.

 

Publications


📝 A High-Carbohydrate Diet Induces Cognitive Impairment and Promotes Amyloid Burden and Tau Phosphorylation via PI3K/Akt/GSK-3β Pathway in db/db Mice
Author: Jialu Xu; Lei Xie; Jiaxin Yin; Xiaoli Shi; Kun Dong; Jing Tao; Weijie Xu; Delin Ma; Shujun Zhang; Juan Chen et al.
Journal: Biomedicines
Year: 2024


 

Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Maastricht University | Netherlands

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Fang Wang's academic journey began with a Bachelor’s degree in Pharmacology from Nanchang University, where she developed an oxidative stress model in LO2 cells to test stress amelioration compounds. She continued her studies with a Master's degree in Cell Biology at the same university, focusing on the role of progesterone adiponectin receptor 7 in reproduction and differences in protein post-translational modifications. Currently, she is pursuing a PhD in Cell Biology at Maastricht University, investigating substrate metabolism in diabetic cardiomyopathy and novel treatments using bioactive components from Traditional Chinese Medicine.

Professional Endeavors 🔬

With over seven years of experience, Dr. Wang has built a strong foundation in preclinical research, drug development, scientific communication, and project management. Her professional career includes internships at Shanghai ChemPartner Co., Ltd. and Jiangxi Zhby Biotech Co. Ltd., where she gained hands-on experience in molecular biology testing and research planning. Her current roles involve significant contributions to research in metabolic disorders and male infertility, with a focus on protein translocation and endosome pH regulation.

Contributions and Research Focus 🌟

Dr. Wang’s research primarily targets the intersection of metabolic disorders and drug development, specifically focusing on diabetic cardiomyopathy and the impact of Traditional Chinese Medicine on cardiac health. Her work includes investigating novel treatment strategies and exploring the mechanisms of substrate metabolism, protein translocation, and endosome pH regulation. Her expertise spans a wide range of molecular and cell biology techniques, including advanced imaging and bioinformatics.

Accolades and Recognition 🏆

Dr. Wang has made notable contributions to the field through her publications and presentations at various conferences. Her research on lipid-induced contractile dysfunction and diabetic cardiomyopathy has been recognized in leading journals and upcoming publications. Her work is highly regarded in the scientific community, reflecting her commitment to advancing healthcare solutions.

Impact and Influence 🌍

Dr. Wang's research has a profound impact on understanding and treating metabolic disorders, particularly in diabetic cardiomyopathy. Her innovative approaches and exploration of traditional medicine offer promising solutions for improving patient outcomes and advancing the field of metabolic disease research. Her contributions are shaping new therapeutic strategies and enhancing the quality of life for patients.

Legacy and Future Contributions 🚀

Dr. Wang's future endeavors are set to further explore and develop cutting-edge healthcare solutions. Her ongoing research aims to refine treatment strategies for metabolic disorders and improve the efficacy of drug development. By integrating advanced techniques and traditional medicine, she is poised to make significant strides in the field, contributing to a healthier future and advancing scientific knowledge.

 

Publications 📕


  • 📝 Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes
    • Authors: Fang Wang, Dietbert Neumann, Dimitrios Kapsokalyvas, Martijn Hoes, Francesco Schianchi, Jan Glatz, Miranda Nabben, Joost J. F. P. Luiken
    • Journal: International Journal of Molecular Sciences
    • Year: 2024

  • 📝 Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
    • Authors: Shujin Wang, Han YinYing, Ruimin Liu, Hou M, Dietbert Neumann, Jun Zhang, Wang F, Yumeng Li, Zhao X, Francesco Schianchi et al.
    • Journal: Circulation Research
    • Year: 2024

  • 📝 Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice
    • Authors: Li J, Liu Y, He J, Wu Z, Wang F, Huang J, Zheng L, Luo T
    • Journal: Journal of Ovarian Research
    • Year: 2024

  • 📝 CD36 as a target for metabolic modulation therapy in cardiac disease
    • Authors: Glatz JFC, Wang F, Miranda Nabben, Luiken JJFP
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2021

  • 📝 Diet-induced obesity is associated with altered expression of sperm motility-related genes and testicular post-translational modifications in a mouse model
    • Authors: Wang F, Chen H, Chen Y, Cheng Y, Li J, Zheng L, Zeng X, Luo T
    • Journal: Theriogenology
    • Year: 2020